SP
PFE icon

Stablepoint Partners’s Pfizer PFE Stock Holding History

Stablepoint Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
201,036
+2,790
+1% +$73K 0.67% 58
2026
Q1 		$5.57M Buy
198,246
+32,318
+19% +$860K 0.83% 43
2025
Q4 		$4.13M Sell
165,928
-16,911
-9% -$426K 0.64% 55
2025
Q3 		$4.66M Buy
182,839
+16,104
+10% +$397K 0.74% 50
2025
Q2 		$4.04M Buy
166,735
+5,615
+3% +$131K 0.69% 53
2025
Q1 		$4.08M Buy
161,120
+29,249
+22% +$765K 0.74% 52
2024
Q4 		$3.5M Sell
131,871
-3,717
-3% -$101K 0.64% 54
2024
Q3 		$3.92M Buy
135,588
+1,032
+0.8% +$30.1K 0.72% 54
2024
Q2 		$4.13M Buy
134,556
+33,529
+33% +$923K 0.8% 50
2024
Q1 		$2.8M Buy
101,027
+10,130
+11% +$281K 0.57% 60
2023
Q4 		$2.62M Buy
+90,897
New +$2.75M 0.67% 54

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Stablepoint Partners's PFE Position: Q2 2026 in Review

Stablepoint Partners increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $73K and bringing the position to 201,036 shares worth $4.84M. The position accounts for 0.67% of the portfolio, ranked #58.

Stablepoint Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.57M in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stablepoint Partners held 201,036 shares of Pfizer worth $4.84M as of Q2 2026.
  • Stablepoint Partners bought 2,790 Pfizer shares in Q2 2026, an estimated $73K.
  • Pfizer made up 0.67% of Stablepoint Partners's portfolio in Q2 2026, its #58 holding.
  • Stablepoint Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Stablepoint Partners's Pfizer position peaked at $5.57M in Q1 2026.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.